BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sperling K, Priddy A, Suntharam N, Feuerhake T. Optimizing testing for Clostridium difficile infection: A quality improvement project. Am J Infect Control 2019;47:340-2. [PMID: 30420098 DOI: 10.1016/j.ajic.2018.08.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Figueroa Castro CE, Munoz-price LS. Advances in Infection Control for Clostridioides (Formerly Clostridium) difficile Infection. Curr Treat Options Infect Dis 2019;11:12-22. [DOI: 10.1007/s40506-019-0179-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Emberger J, Hitchcock MM, Markley JD. Diagnostic Stewardship Approaches to Clostridioides difficile Infection in the Era of Two-Step Testing: a Shifting Landscape. Curr Treat Options Infect Dis 2020;12:258-74. [DOI: 10.1007/s40506-020-00223-8] [Reference Citation Analysis]
3 Woods-Hill CZ, Colantuoni EA, Koontz DW, Voskertchian A, Xie A, Thurm C, Miller MR, Fackler JC, Milstone AM, Agulnik A, Albert JE, Auth MJ, Bradley E, Clayton JA, Coffin SE, Dallefeld S, Ezetendu CP, Fainberg NA, Flaherty BF, Foster CB, Hauger SB, Hong SJ, Hysmith ND, Kirby AL, Kociolek LK, Larsen GY, Lin JC, Linam WM, Newland JG, Nolt D, Priebe GP, Sandora TJ, Schwenk HT, Smith CM, Steffen KM, Tadphale SD, Toltzis P, Wolf J, Zerr DM; Bright STAR Authorship Group. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative. JAMA Pediatr 2022. [PMID: 35499841 DOI: 10.1001/jamapediatrics.2022.1024] [Reference Citation Analysis]
4 Zaver HB, Moktan VP, Harper EP, Bali A, Nasir A, Foulks C, Kuhlman J, Green M, Algan GA, Parth HC, Wu-Ballis M, DiCicco S, Smith BT, Owen RN, Mai LS, Spiros SL, Griffis J, Ramsey Walker DT, Hata DJ, Oring JM, Powers HR, Bosch W. Reduction in Health Care Facility-Onset Clostridioides difficile Infection: A Quality Improvement Initiative. Mayo Clin Proc Innov Qual Outcomes 2021;5:1066-74. [PMID: 34820598 DOI: 10.1016/j.mayocpiqo.2021.09.004] [Reference Citation Analysis]
5 Karlovich NS, Sata SS, Griffith B, Coop A, Kalu IC, Engemann JJ, Seidelman J, Turner NA, Polage CR, Smith BA, Lewis SS. In pursuit of the holy grail: Improving C. difficile testing appropriateness with iterative electronic health record clinical decision support and targeted test restriction. Infect Control Hosp Epidemiol 2021;:1-8. [PMID: 34085622 DOI: 10.1017/ice.2021.228] [Reference Citation Analysis]
6 Sick-samuels AC, Woods-hill C. Diagnostic Stewardship in the Pediatric Intensive Care Unit. Infectious Disease Clinics of North America 2022;36:203-18. [DOI: 10.1016/j.idc.2021.11.003] [Reference Citation Analysis]
7 Khuvis J, Alsoubani M, Mae Rodday A, Doron S. Impact of Diagnostic Stewardship Interventions on Clostridiodes difficile test ordering practices and results. Clinical Biochemistry 2022. [DOI: 10.1016/j.clinbiochem.2022.03.009] [Reference Citation Analysis]
8 Olmedo M, Valerio M, Reigadas E, Marín M, Alcalá L, Muñoz P, Bouza E. Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention. JAC Antimicrob Resist 2020;2:dlaa037. [PMID: 34223003 DOI: 10.1093/jacamr/dlaa037] [Reference Citation Analysis]
9 Boly FJ, Reske KA, Kwon JH. The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities. Curr Infect Dis Rep 2020;22:7. [PMID: 33762897 DOI: 10.1007/s11908-020-0715-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Sick-Samuels AC, Linz M, Bergmann J, Fackler JC, Berenholtz SM, Ralston SL, Hoops K, Dwyer J, Colantuoni E, Milstone AM. Diagnostic Stewardship of Endotracheal Aspirate Cultures in a PICU. Pediatrics 2021;147:e20201634. [PMID: 33827937 DOI: 10.1542/peds.2020-1634] [Reference Citation Analysis]